Article info
Extended report
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
- Dr Van den Bosch Email: eric.veys{at}rug.ac.be
Citation
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
Publication history
- Accepted March 27, 2000
- First published June 1, 2000.
Online issue publication
April 05, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Annals of the Rheumatic Diseases